Pages that link to "Q34349749"
Jump to navigation
Jump to search
The following pages link to Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature (Q34349749):
Displaying 50 items.
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis (Q22242062) (← links)
- Does BCG have a role in tuberculosis control and prevention in the United Kingdom? (Q22242220) (← links)
- Tuberculosis vaccines: beyond bacille Calmette-Guerin (Q22242669) (← links)
- Interventions for increasing the uptake of immunisation in healthcare workers (Q24188178) (← links)
- Randomisation to protect against selection bias in healthcare trials (Q24245576) (← links)
- Tuberculosis: 13. Control of the disease among aboriginal people in Canada (Q24534732) (← links)
- The continuing challenges of leprosy (Q24545809) (← links)
- Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer (Q24548647) (← links)
- A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis (Q24554444) (← links)
- Observational versus experimental studies: what's the evidence for a hierarchy? (Q24558950) (← links)
- In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG (Q24599551) (← links)
- Randomized, controlled trials, observational studies, and the hierarchy of research designs (Q24670544) (← links)
- Tuberculous meningitis (Q24672894) (← links)
- Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model (Q24675231) (← links)
- A second-generation anti TB vaccine is long overdue (Q24800887) (← links)
- Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system (Q24805951) (← links)
- A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447] (Q25257302) (← links)
- Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis (Q26744042) (← links)
- Immune oxysterols: Role in mycobacterial infection and inflammation (Q26751406) (← links)
- Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children (Q26774267) (← links)
- Tuberculosis vaccines and prevention of infection (Q26782022) (← links)
- Transformative tools for tackling tuberculosis (Q26784084) (← links)
- Efficacy and Acceptability of Orthokeratology for Slowing Myopic Progression in Children: A Systematic Review and Meta-Analysis (Q26801913) (← links)
- Recent advances towards tuberculosis control: vaccines and biomarkers (Q26859739) (← links)
- Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis (Q26863391) (← links)
- Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium (Q26865560) (← links)
- Prime-boost approaches to tuberculosis vaccine development (Q27024526) (← links)
- Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis (Q27027912) (← links)
- Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model (Q27309052) (← links)
- Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice (Q27311568) (← links)
- Crystal Structure of Bovine CD1b3 with Endogenously Bound Ligands (Q27662107) (← links)
- Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis (Q28082627) (← links)
- Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? (Q28083377) (← links)
- Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice (Q28218674) (← links)
- Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (Q28243702) (← links)
- Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination (Q28350972) (← links)
- Sun protection to improve vaccine effectiveness in children in a high ambient ultraviolet radiation and rural environment: an intervention study (Q28365025) (← links)
- Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis (Q28375163) (← links)
- A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data (Q28383049) (← links)
- Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool (Q28390218) (← links)
- Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa (Q28473318) (← links)
- Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis (Q28486541) (← links)
- Mycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functions (Q28486947) (← links)
- Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis (Q28487469) (← links)
- Tuberculin skin test result and risk of death among persons with active TB (Q28535009) (← links)
- Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study (Q28603191) (← links)
- Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A (Q28649845) (← links)
- A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults (Q28729028) (← links)
- Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis (Q28730427) (← links)
- Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression (Q28740799) (← links)